Epstein Secrets

HARRY BELLER C/O HBRK ASSOCIATES 301 E 66TH ST APT 10F NEW YORK NY 10065-6216 EFTA01539938 EFTA01539939 For the Period 8/1/12 to 8/31/12 Account Summary

sition. Please contact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 146.59 09062X-10-3 BIIB 18.06 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/13 80% CONTIN BARRIER- 10.5%CPN 15% CAP

HARRY BELLER C/O HBRK ASSOCIATES 301 E 66TH ST APT 10F NEW YORK NY 10065-6216 EFTA01539592 EFTA01539593 For the Period 4/1/12 to 4/30/12 Account Summary

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 134.01 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

HARRY BELLER C/O HBRK ASSOCIATES 301 E 66TH ST APT 10F NEW YORK NY 10065-6216 EFTA01539675 EFTA01539676 For the Period 5/1/12 to 5/31/12 Account Summary

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 130.75 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

HARRY BELLER C/O HBRK ASSOCIATES 301 E 66TH ST APT 10F NEW YORK NY 10065-6216 EFTA01540036 EFTA01540037 For the Period 9/1/12 to 9/30/12 Account Summary

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 149.21 09062X-10-3 BIIB 21.66 30303M-10-2 FB Total US Large Cap Equity $1,091,957.30 $1,166,930.47 ($74,973

HARRY BELLER C/O HBRK ASSOCIATES 301 E 66TH ST APT 10F NEW YORK NY 10065-6216 EFTA01539497 EFTA01539498 For the Period 3/1/12 to 3/31/12 Account Summary

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 126.00 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

HARRY BELLER C/O HBRK ASSOCIATES 301 E 66TH ST APT 10F NEW YORK NY 10065-6216 EFTA01539756 EFTA01539757 For the Period 6/1/12 to 6/30/12 Account Summary

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 144.38 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

HARRY BELLER C/O HBRK ASSOCIATES 301 E 66TH ST APT 10F NEW YORK NY 10065-6216 EFTA01539853 EFTA01539854 For the Period 7/1/12 to 7/31/12 Account Summary

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 145.83 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

HARRY BELLER C/O HBRK ASSOCIATES 301 E 66TH ST APT 10F NEW YORK NY 10065-6216 EFTA01540135 EFTA01540136 For the Period 10/1/12 to 10/31/12 Account Summar

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC DEAN FOODS CO FACEBOOK INC-A 04033A-10-0 ARIA 138.21 09062X-10-3 BIIB 16.84 242370-10-4 DF 21.11 30303M-10-2 FB Total US Large Cap Equity $1